Study uses donor cord blood to restore blood cell production
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study tests giving you donated umbilical cord blood through an IV to help your body rebuild blood-forming cells after chemotherapy. It may help people who need a stem-cell “reset” using a specific type of cord blood unit that meets strict matching and safety rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a condition that has an IRB-approved treatment plan requiring cord blood for stem-cell recovery after chemotherapy
- You (or your parent/guardian) can sign consent to use an unlicensed cord blood unit in a University of Minnesota trial
- You have an unlicensed cord blood unit available that matches the study’s required cell dose and tissue (HLA) matching
- Your cord blood unit must test negative for common blood-borne infections
- There is no “equivalent,” licensed cord blood unit available from an approved University of Minnesota cord blood bank
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This trial tests a higher dose of UM171 to make cord blood transplants safer and more effective for people with certain blood cancers or bone marrow diseases. It aims to help patients who don't have a suitable donor.
This trial studies whether unlicensed (not FDA-approved) cord blood units made by a specific program are safe to use for unrelated transplants. It may help doctors confirm safe ways to use these units for people who need a transplant for blood-forming system disorders.
This study tests if infusing umbilical cord blood cells can safely improve blood counts after chemotherapy in adults aged 60–80 with MDS or AML who have bone marrow suppression. If you qualify, you may receive a treatment that could help your body recover its ability to make healthy blood cells.
Hear when a new Lymphatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.